Searchable abstracts of presentations at key conferences in endocrinology
Previous issue | Volume 49 | ECE2017 | Next issue

19th European Congress of Endocrinology

Lisbon, Portugal
20 May 2017 - 23 May 2017

Card image cap
20-23 May 2017, Lisbon, Portugal Further information

DEBATES

Is there a role for medical therapy for non-functioning pituitary adenomas?

ea0049d1.1 | Is there a role for medical therapy for non-functioning pituitary adenomas? | ECE2017

Is there a role for medical therapy for non- functioning pituitary adenomas? - FOR

Greenman Yona

In this debate I will make an overview of outcomes of NFPA patients with post-operative remnants, who were treated conservatively after surgery. In view of the high rates of tumor progression with consequent need for repeated surgery and radiation therapy, we propose the use of dopamine agonists in these patients. Recent data showing that preventive treatment with dopamine agonists significantly reduces the rate of tumor progression and the need for radiation therapy or additi...

ea0049d1.2 | Is there a role for medical therapy for non-functioning pituitary adenomas? | ECE2017

Is there a role for medical therapy for non- functioning pituitary adenomas? - AGAINST

Tsagarakis Stylianos

Non-functioning pituitary adenomas (NFPA) are the second most common variant of pituitary tumors. They are presented by compression symptoms, hypopituitarism and in rec as incidental findings during brain imaging. When symptomatic, primary therapy for NFPAs is surgery most commonly by the trans-sphenoidal (TSS) approach. Medical therapy is not generally recommended in this setting, particularly when immediate decompression of the optic chiasm is needed. Despite the debulking e...